{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:14:47Z","timestamp":1790201687780,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.semperi.2021.151393","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T23:30:29Z","timestamp":1611444629000},"page":"151393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies"],"prefix":"10.1016","volume":"45","author":[{"given":"Scott D.","family":"Grosse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila C.","family":"Dollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael R.","family":"Ortega-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.semperi.2021.151393_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.semperi.2018.02.002","article-title":"Congenital cytomegalovirus infection","volume":"42","author":"Fowler","year":"2018","journal-title":"Semin Perinatol"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0002","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.semperi.2021.151393_bib0003","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2007.09.004","article-title":"Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment","volume":"41","author":"Grosse","year":"2008","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.semperi.2021.151393_bib0004","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","article-title":"Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection","volume":"164","author":"Dreher","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.semperi.2021.151393_bib0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2431-13-90","article-title":"Laboratory testing and diagnostic coding for cytomegalovirus among privately insured infants in the United States: a retrospective study using administrative claims data","volume":"13","author":"Leung","year":"2013","journal-title":"BMC Pediatr"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0006","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/archdischild-2017-312805","article-title":"Healthcare costs attributable to congenital cytomegalovirus infection","volume":"103","author":"Korndewal","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.semperi.2021.151393_bib0007","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpeds.2015.10.069","article-title":"Symptomatic congenital cytomegalovirus infection Is underdiagnosed in British Columbia","volume":"169","author":"Sorichetti","year":"2016","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.semperi.2021.151393_bib0008","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-0039-1683958","article-title":"Cytomegalovirus infection among infants in neonatal intensive care units, California, 2005 to 2016","volume":"37","author":"Tran","year":"2020","journal-title":"Am J Perinatol"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0009","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.2014-1173","article-title":"Hearing loss and congenital CMV infection: a systematic review","volume":"134","author":"Goderis","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.semperi.2021.151393_bib0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2018.04.043","article-title":"Racial and ethnic differences in the prevalence of congenital cytomegalovirus infection","volume":"200","author":"Fowler","year":"2018","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.semperi.2021.151393_bib0011","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/jp.2017.41","article-title":"Long-term outcomes of children with symptomatic congenital cytomegalovirus disease","volume":"37","author":"Lanzieri","year":"2017","journal-title":"J Perinatol"},{"issue":"12","key":"10.1016\/j.semperi.2021.151393_bib0012","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/dmcn.13556","article-title":"Long-term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study","volume":"59","author":"Korndewal","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0013","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/rmv.1790","article-title":"Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?","volume":"24","author":"Cannon","year":"2014","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.semperi.2021.151393_bib0014","first-page":"26","article-title":"The epidemiology and public health impact of congenital cytomegalovirus infection","volume":"2","author":"Cannon","year":"2013"},{"issue":"1","key":"10.1016\/j.semperi.2021.151393_bib0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"J Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.semperi.2021.151393_bib0016","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2610","article-title":"Hearing loss in children with asymptomatic congenital cytomegalovirus infection","volume":"139","author":"Lanzieri","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0017","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1517","article-title":"Intelligence and academic achievement with asymptomatic congenital cytomegalovirus infection","volume":"140","author":"Lopez","year":"2017","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.semperi.2021.151393_bib0018","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/INF.0000000000001599","article-title":"Long-term visual and ocular sequelae in patients with congenital cytomegalovirus infection","volume":"36","author":"Jin","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.semperi.2021.151393_bib0019","series-title":"Cytomegaloviruses: From Molecular Pathogenesis to Intervention","first-page":"49","article-title":"The economic impact of congenital CMV infection: methods and estimates","author":"Grosse","year":"2013"},{"issue":"12","key":"10.1016\/j.semperi.2021.151393_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.23949","article-title":"Estimated cost-effectiveness of newborn screening for congenital cytomegalovirus infection in China using a Markov model","volume":"3","author":"Chen","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.semperi.2021.151393_bib0021","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","article-title":"Cost-of-illness studies","volume":"29","author":"Larg","year":"2011","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.semperi.2021.151393_bib0022","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40258-018-0416-4","article-title":"Friction cost estimates of productivity costs in cost-of-illness studies in comparison with human capital estimates: a review","volume":"16","author":"Pike","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"issue":"7 Suppl 1","key":"10.1016\/j.semperi.2021.151393_bib0023","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/MLR.0b013e3181a2d847","article-title":"Overview of methods to estimate the medical costs of cancer","volume":"47","author":"Barlow","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.semperi.2021.151393_bib0024","series-title":"Preterm birth: causes, consequences, and prevention","author":"Behrman","year":"2007"},{"key":"10.1016\/j.semperi.2021.151393_bib0025","series-title":"Updating national preterm birth costs to 2016 with separate estimates for individual states","author":"Waitzman","year":"2019"},{"key":"10.1016\/j.semperi.2021.151393_bib0026","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2015"},{"issue":"1","key":"10.1016\/j.semperi.2021.151393_bib0027","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40273-015-0325-4","article-title":"Cost-of-illness studies: an updated review of current methods","volume":"34","author":"Onukwugha","year":"2016","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.semperi.2021.151393_bib0028","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40273-019-00782-9","article-title":"Quantifying family spillover effects in economic evaluations: measurement and valuation of informal care time","volume":"37","author":"Grosse","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.semperi.2021.151393_bib0029","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"issue":"10","key":"10.1016\/j.semperi.2021.151393_bib0030","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"Suppl 4","key":"10.1016\/j.semperi.2021.151393_bib0031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1528-1157.43.s.4.2.x","article-title":"The economic cost of epilepsy: a review of the literature","volume":"43","author":"Begley","year":"2002","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.semperi.2021.151393_bib0032","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1160\/TH11-09-0666","article-title":"Incidence-based cost estimates require population-based incidence data. a critique of Mahan et\u00a0al","volume":"107","author":"Grosse","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semperi.2021.151393_bib0033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2015.11.033","article-title":"The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs","volume":"137","author":"Grosse","year":"2016","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.semperi.2021.151393_bib0034","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.clinthera.2019.04.022","article-title":"The economic burden of congenital cytomegalovirus disease in the first year of life: a retrospective analysis of health insurance claims data in the United States","volume":"41","author":"Meyers","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.semperi.2021.151393_bib0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpeds.2018.03.036","article-title":"Risk factors, geographic distribution, and healthcare burden of symptomatic congenital cytomegalovirus infection in the United States: analysis of a nationally representative database, 2000-2012","volume":"199","author":"Inagaki","year":"2018","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.semperi.2021.151393_bib0036","doi-asserted-by":"crossref","first-page":"A784","DOI":"10.1016\/j.jval.2017.08.2289","article-title":"The economic burden of congenital cytomegalovirus-related hospitalizations in the United States","volume":"20","author":"Candrilli","year":"2017","journal-title":"Val Health"},{"issue":"11","key":"10.1016\/j.semperi.2021.151393_bib0037","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/INF.0000000000000421","article-title":"Congenital cytomegalovirus-related hospitalizations in infants <1 year of age, United States, 1997-2009","volume":"33","author":"Lopez","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.semperi.2021.151393_bib0038","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clinthera.2018.01.006","article-title":"Valganciclovir use among commercially and Medicaid-insured infants with congenital CMV infection in the United States, 2009-2015","volume":"40","author":"Leung","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.semperi.2021.151393_bib0039","article-title":"Blood viral load in the diagnostic workup of congenital cytomegalovirus infection","volume":"122","author":"Smiljkovic","year":"2019","journal-title":"J Clin Virol"},{"issue":"7","key":"10.1016\/j.semperi.2021.151393_bib0040","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1017\/S0950268815002708","article-title":"Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence","volume":"144","author":"Korndewal","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.semperi.2021.151393_bib0041","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/421999","article-title":"National Vaccine Advisory C. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee","volume":"39","author":"Arvin","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0042","first-page":"392","article-title":"Congenital cytomegalovirus infection-a question of screening","volume":"9","author":"Rahav","year":"2007","journal-title":"Isr Med Assoc J"},{"issue":"27","key":"10.1016\/j.semperi.2021.151393_bib0043","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1016\/j.vaccine.2012.04.011","article-title":"Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus","volume":"30","author":"Dempsey","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.semperi.2021.151393_bib0044","series-title":"Congenital Cytomegalovirus Infection","first-page":"121","article-title":"How to save money: congenital CMV infection and the economy","author":"Walter","year":"2018"},{"key":"10.1016\/j.semperi.2021.151393_bib0045","series-title":"Vaccines for the 21st century: a tool for decisionmaking","author":"Lawrence","year":"2001"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0046","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00365549950163969","article-title":"Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. review of prospective studies available in the literature","volume":"31","author":"Ahlfors","year":"1999","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.semperi.2021.151393_bib0047","first-page":"207","article-title":"Economic costs of mental retardation, cerebral palsy, hearing loss, and vision impairment","volume":"3","author":"Honeycutt","year":"2003"},{"issue":"6","key":"10.1016\/j.semperi.2021.151393_bib0048","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/archdischild-2018-316010","article-title":"Economic cost of congenital CMV in the UK","volume":"104","author":"Retzler","year":"2019","journal-title":"Arch Dis Child"},{"issue":"9","key":"10.1016\/j.semperi.2021.151393_bib0049","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/adc.66.9.1068","article-title":"Outcome of confirmed symptomatic congenital cytomegalovirus infection","volume":"66","author":"Ramsay","year":"1991","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.semperi.2021.151393_bib0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jpeds.2016.10.024","article-title":"Congenital cytomegalovirus among children with cerebral palsy","volume":"181","author":"Smithers-Sheedy","year":"2017","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.semperi.2021.151393_bib0051","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/ped.13433","article-title":"Congenital cytomegalovirus in Japan: more than 2 year follow up of infected newborns","volume":"60","author":"Koyano","year":"2018","journal-title":"Pediatr Int"},{"issue":"13","key":"10.1016\/j.semperi.2021.151393_bib0052","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1056\/NEJMicm1800262","article-title":"Congenital cytomegalovirus infection","volume":"379","author":"Kawai","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.semperi.2021.151393_bib0053","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00268-17","article-title":"Progress toward development of a vaccine against congenital cytomegalovirus infection","volume":"24","author":"Schleiss","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"Supplement_1","key":"10.1016\/j.semperi.2021.151393_bib0054","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1093\/infdis\/jiz402","article-title":"Review of mathematical models of vaccination for preventing congenital cytomegalovirus infection","volume":"221","author":"Lanzieri","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.semperi.2021.151393_bib0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.vaccine.2015.11.039","article-title":"Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US","volume":"34","author":"Alfaro-Murillo","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.semperi.2021.151393_bib0056","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.semperi.2021.151393_bib0057","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2016.02.042","article-title":"Diagnosis and antenatal management of congenital cytomegalovirus infection","volume":"214","author":"Hughes","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"10253","key":"10.1016\/j.semperi.2021.151393_bib0058","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.semperi.2021.151393_bib0059","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajog.2020.02.018","article-title":"Cytomegalovirus infection during pregnancy: state of the science","volume":"223","author":"Leruez-Ville","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.semperi.2021.151393_bib0060","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ebiom.2015.08.003","article-title":"Prevention of primary cytomegalovirus infection in pregnancy","volume":"2","author":"Revello","year":"2015","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.semperi.2021.151393_bib0061","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0789","article-title":"Outcomes from a hearing-targeted cytomegalovirus screening program","volume":"139","author":"Diener","year":"2017","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.semperi.2021.151393_bib0062","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/lary.26819","article-title":"Should infants who fail their newborn hearing screen undergo cytomegalovirus testing?","volume":"128","author":"Park","year":"2018","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.semperi.2021.151393_bib0063","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jpids\/pix105","article-title":"Results of a targeted screening program for congenital cytomegalovirus infection in infants who fail newborn hearing screening","volume":"8","author":"Vancor","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.semperi.2021.151393_bib0064","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpeds.2018.03.062","article-title":"Closer to universal newborn screening for congenital cytomegalovirus infection but far away from antiviral therapy in all infected infants","volume":"199","author":"Ross","year":"2018","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.semperi.2021.151393_bib0065","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.semperi.2021.151393_bib0066","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/INF.0000000000001763","article-title":"Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management","volume":"36","author":"Luck","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.semperi.2021.151393_bib0067","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pcl.2012.12.008","article-title":"Congenital cytomegalovirus infection: new prospects for prevention and therapy","volume":"60","author":"Swanson","year":"2013","journal-title":"Pediatr Clin North Am"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0068","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00431-019-03558-7","article-title":"Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study","volume":"179","author":"Dorfman","year":"2020","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.semperi.2021.151393_bib0069","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3837","article-title":"Screening for congenital cytomegalovirus after newborn hearing screening: What comes next?","volume":"139","author":"Grosse","year":"2017","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.semperi.2021.151393_bib0070","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/archdischild-2017-314404","article-title":"Does screening for congenital cytomegalovirus at birth improve longer term hearing outcomes?","volume":"103","author":"Hilditch","year":"2018","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.semperi.2021.151393_bib0071","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/clinids\/12.1.31","article-title":"Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease","volume":"12","author":"Porath","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"10","key":"10.1016\/j.semperi.2021.151393_bib0072","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.vaccine.2018.01.042","article-title":"Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France","volume":"36","author":"N'Diaye","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.semperi.2021.151393_bib0073","first-page":"57","article-title":"Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment\u2013United States, 2003","volume":"53","year":"2004","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.semperi.2021.151393_bib0074","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/cid\/cit018","article-title":"Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom","volume":"56","author":"Townsend","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0075","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2009.07.056","article-title":"Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? a decision-analytic and economic analysis","volume":"201","author":"Cahill","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.semperi.2021.151393_bib0076","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1055\/s-0038-1676495","article-title":"Cytomegalovirus screening in pregnancy: a cost-effectiveness and threshold analysis","volume":"36","author":"Albright","year":"2019","journal-title":"Am J Perinatol"},{"issue":"12","key":"10.1016\/j.semperi.2021.151393_bib0077","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.ijporl.2015.09.019","article-title":"Cost-benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection","volume":"79","author":"Bergevin","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6","key":"10.1016\/j.semperi.2021.151393_bib0078","doi-asserted-by":"crossref","first-page":"F501","DOI":"10.1136\/archdischild-2014-306756","article-title":"First estimates of the potential cost and cost saving of protecting childhood hearing from damage caused by congenital CMV infection","volume":"100","author":"Williams","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"12","key":"10.1016\/j.semperi.2021.151393_bib0079","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapediatrics.2016.2016","article-title":"Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection","volume":"170","author":"Gantt","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"11","key":"10.1016\/j.semperi.2021.151393_bib0080","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/jpc.14428","article-title":"Integration of congenital cytomegalovirus screening within a newborn hearing screening programme","volume":"55","author":"Beswick","year":"2019","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.semperi.2021.151393_bib0081","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijporl.2018.12.027","article-title":"Long-term hearing outcomes of children with symptomatic congenital CMV treated with valganciclovir","volume":"118","author":"McCrary","year":"2019","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"7 Suppl 1","key":"10.1016\/j.semperi.2021.151393_bib0082","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/MLR.0b013e31819c9571","article-title":"Economic productivity by age and sex: 2007 estimates for the United States","volume":"47","author":"Grosse","year":"2009","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.semperi.2021.151393_bib0083","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/13696998.2018.1542520","article-title":"Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations","volume":"22","author":"Grosse","year":"2019","journal-title":"J Med Econ"},{"issue":"1","key":"10.1016\/j.semperi.2021.151393_bib0084","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/INF.0000000000002922","article-title":"Late-onset hearing loss from congenital cytomegalovirus infection after newborn period in a highly immune population in China","volume":"40","author":"Wang","year":"2021","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0085","doi-asserted-by":"crossref","first-page":"e6007","DOI":"10.1097\/MD.0000000000006007","article-title":"Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.semperi.2021.151393_bib0086","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s11136-008-9358-x","article-title":"Health state preference scores for children with permanent childhood hearing loss: a comparative analysis of the QWB and HUI3","volume":"17","author":"Smith-Olinde","year":"2008","journal-title":"Qual Life Res"},{"key":"10.1016\/j.semperi.2021.151393_bib0087","series-title":"Infectious Disease of the Fetus and Newborn Infant","first-page":"706","article-title":"Cytomegalovirus","author":"Britt","year":"2011"},{"issue":"12","key":"10.1016\/j.semperi.2021.151393_bib0088","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1136\/adc.59.12.1120","article-title":"Congenital cytomegalovirus infection","volume":"59","author":"Preece","year":"1984","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.semperi.2021.151393_bib0089","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archpedi.1982.03970460026006","article-title":"The outcome in children with congenital cytomegalovirus infection. a longitudinal follow-up study","volume":"136","author":"Saigal","year":"1982","journal-title":"Am J Dis Child"},{"issue":"1","key":"10.1016\/j.semperi.2021.151393_bib0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0272989X02239651","article-title":"Economic evaluation of vaccination programs: the impact of herd-immunity","volume":"23","author":"Brisson","year":"2003","journal-title":"Med Decis Making"},{"issue":"33","key":"10.1016\/j.semperi.2021.151393_bib0091","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1016\/j.vaccine.2010.05.056","article-title":"Understanding differences in predictions of HPV vaccine effectiveness: a comparative model-based analysis","volume":"28","author":"Van de Velde","year":"2010","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.semperi.2021.151393_bib0092","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2014.05.014","article-title":"Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection","volume":"32","author":"Lanzieri","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.semperi.2021.151393_bib0093","first-page":"1385","article-title":"Newborn screening for congenital cytomegalovirus infection...it is time","volume":"70","author":"Demmler Harrison","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.semperi.2021.151393_bib0094","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/14787210.2017.1303377","article-title":"Encouraging postnatal cytomegalovirus (CMV) screening: the time is NOW for universal screening!","volume":"15","author":"Ronchi","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.semperi.2021.151393_bib0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpeds.2018.02.028","article-title":"Valganciclovir Is beneficial in children with congenital cytomegalovirus and isolated hearing loss","volume":"199","author":"Pasternak","year":"2018","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.semperi.2021.151393_bib0096","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/ijns4030025","article-title":"What contribution did economic evidence make to the adoption of universal newborn hearing screening policies in the United States?","volume":"4","author":"Grosse","year":"2018","journal-title":"Int J Neonatal Screen"},{"issue":"13","key":"10.1016\/j.semperi.2021.151393_bib0097","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.2019.14889","article-title":"Driving in the minivan-life as a pediatrician and parent of a child with disabilities","volume":"322","author":"Pesch","year":"2019","journal-title":"JAMA"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000521000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000521000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T12:52:03Z","timestamp":1620737523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000521000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0146000521000069"],"URL":"https:\/\/doi.org\/10.1016\/j.semperi.2021.151393","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semperi.2021.151393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151393"}}